Clinician copilot
Navina
A clinician-first copilot: visit-ready summaries and point-of-care suspects inside the chart. The design fits groups whose capture depends on physician participation.
- Capture model
- Prospective, point-of-care
- AI approach
- EHR-native condition detection over EHR, HIE, and claims data, presented as a clinician copilot
- RADV & audit
- Suspects link back to chart evidence
- Submission lifecycle
- Not its primary focus
- Best fit
- Physician groups and ACOs whose capture happens in the exam room
- Funding
- $55M Series C, March 25, 2025, led by Growth Equity at Goldman Sachs Alternatives
- KLAS note
- Won Best in KLAS in Clinician Digital Workflow in 2025; TransformativeMed took that category in 2026
Navina condenses EHR, HIE, and claims data into something a physician can read in the minutes before a visit, flags conditions worth confirming while the patient is there, and lets the clinician document without leaving the chart. The product is built for the person in the room rather than for the coder downstream, which is why groups that struggle with clinician adoption tend to shortlist it.
Navina raised a $55M Series C on March 25, 2025, led by Growth Equity at Goldman Sachs Alternatives. One detail is worth stating carefully because it circulates wrong: the company’s Best in KLAS award in Clinician Digital Workflow was the 2025 one. TransformativeMed took that category in 2026.
Choose it when
Physician groups and ACOs that want adoption-friendly, point-of-care capture and clinician buy-in.
Look elsewhere when
Plans whose primary need is retrospective volume, RADV response, or submission-lifecycle tracking.
Related profiles
Sources
- Navina: risk adjustment product
- navina.ai (official site)
Positioning summarized from public materials current in August 2026. What a given customer receives depends on contract and scope, so confirm the details with the vendor. Spot an error? Tell us and we will correct it. Back to the full comparison →